Fenwick Represents Omada Health in Acquisition of Physera

Fenwick represented Omada Health, a leading digital care company that offers innovative and clinically effective digital health programs to empower individuals to engage in their health and lead healthier lives, in its acquisition of Physera, a leading musculoskeletal care company that delivers interventions digitally and via telehealth.

Through the deal, Omada adds Physera’s musculoskeletal solution to its suite of digital care programs for the prevention and self-management of diabetes, hypertension, and mental health.

In conjunction with the acquisition, Fenwick also represented Omada in raising an additional round of growth capital from Perceptive Advisors. More information can be obtained from Omada’s announcement.

The Fenwick transaction team for the acquisition included corporate partners Kris Withrow and Michael Esquivel and associates Ryan McRobert, Chance Goldberg and Andrew Webber; executive compensation and employee benefits partners Shawn Lampron and Marshall Mort, and associate Corinne Nhaissi; employment practices associate Reanne Swafford-Harris; technology transactions partner Stefano Quintini and associate Jefferson Lin; and tax partner Idan Netser and associate Marianne Tassone. The Fenwick team for the financing included corporate partner Michael Esquivel and associates Ryan McRobert and Noah Johnson. Fenwick has served as primary outside counsel to Omada Health for several years, led by corporate partner Michael Esquivel.​